Y-Intercept (HK)’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.36M | Buy |
27,832
+22,851
| +459% | +$1.12M | 0.03% | 791 |
|
2025
Q1 | $254K | Sell |
4,981
-6,043
| -55% | -$308K | 0.02% | 956 |
|
2024
Q4 | $498K | Sell |
11,024
-2,805
| -20% | -$127K | 0.03% | 731 |
|
2024
Q3 | $513K | Sell |
13,829
-18,312
| -57% | -$679K | 0.03% | 763 |
|
2024
Q2 | $983K | Buy |
32,141
+5,185
| +19% | +$159K | 0.05% | 499 |
|
2024
Q1 | $784K | Buy |
+26,956
| New | +$784K | 0.06% | 490 |
|
2023
Q2 | – | Sell |
-7,739
| Closed | -$375K | – | 1633 |
|
2023
Q1 | $375K | Buy |
+7,739
| New | +$375K | 0.04% | 668 |
|
2021
Q1 | – | Sell |
-4,376
| Closed | -$267K | – | 765 |
|
2020
Q4 | $267K | Buy |
+4,376
| New | +$267K | 0.11% | 350 |
|